Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0089
0.00 (0.00%)
Mar 5, 2026, 3:50 PM EST
Evofem Biosciences Market Cap
Evofem Biosciences has a market cap or net worth of $1.15 million as of March 5, 2026. Its market cap has increased by 1.70% in one year.
Market Cap
1.15M
Enterprise Value
58.07M
Revenue
17.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since January 18, 2018, Evofem Biosciences's market cap has decreased from 215.21M to 1.15M, a decrease of -99.46%. That is a compound annual growth rate of -47.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 1.15M | -4.21% |
| Dec 31, 2025 | 1.20M | 7.24% |
| Dec 31, 2024 | 1.12M | -12.37% |
| Dec 29, 2023 | 1.28M | -83.76% |
| Dec 30, 2022 | 7.89M | -87.13% |
| Dec 31, 2021 | 61.26M | -68.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exousia Pro | 1.60M |
| inTerra Resources | 1.49M |
| Entia Biosciences | 1.37M |
| Halberd | 1.20M |
| CERo Therapeutics Holdings | 1.14M |
| International Stem Cell | 1.08M |
| Eastgate Biotech | 1.06M |
| Emmaus Life Sciences | 1.02M |